• Rosemary Extract Modulates Apoptosis in Renal Amyloidosis Mo

  2026-06-18

  This study uncovers the multidimensional protective mechanisms of rosemary extract against renal amyloidosis, demonstrating its ability to disrupt amyloid fibrils and attenuate apoptosis via ER stress pathway modulation. These findings provide mechanistic insight for developing adjuvant therapies targeting programmed cell death in amyloid-related renal disease.

• In Vitro Efficacy of Temafloxacin Against Gram-Negative Path

  2026-06-17

  This article analyzes the comprehensive in vitro evaluation of temafloxacin, a fluoroquinolone broad-spectrum antibacterial agent, against clinically significant Gram-negative bacteria. The reference study reveals temafloxacin’s potent activity against a range of respiratory and enteric pathogens, positioning it as a valuable research tool for infection biology and antibacterial susceptibility profiling.

• Panobinostat-Induced Calcineurin Degradation in Multiple Mye

  2026-06-17

  The reference study reveals that panobinostat, a histone deacetylase inhibitor, induces degradation of calcineurin (PPP3CA) in multiple myeloma cells, thereby enhancing antimyeloma efficacy and overcoming bortezomib resistance. These findings identify a new molecular vulnerability in refractory multiple myeloma and provide a rationale for combination therapeutic strategies.

• Optimized hGBA1 mRNA Restores Lysosomal Function in Gaucher

  2026-06-16

  The referenced study presents a rationally engineered human GBA1 mRNA that significantly enhances glucocerebrosidase expression and lysosomal targeting in cellular and animal models of Gaucher disease. By improving mRNA stability and translation, the approach provides a promising alternative to enzyme replacement therapy, with direct implications for lysosomal storage disorder research and therapeutic innovation.

• n-Dodecyl-β-D-maltoside: Precision Detergent for Membrane Pr

  2026-06-16

  n-Dodecyl-β-D-maltoside (DDM) is a benchmark non-ionic detergent for membrane protein purification, enabling gentle solubilization while preserving protein activity. Its low critical micelle concentration and compatibility with structural biology workflows make it indispensable for integrin and multi-subunit complex research. APExBIO supplies DDM (C4421), a reagent trusted for reliable membrane protein stabilization in advanced assays.

• CDK9 Inhibitor (A3294): Technical Use and Protocol Guidance

  2026-06-15

  CDK9 inhibitor (A3294) enables selective inhibition of cyclin dependent kinase 9, supporting research into transcription elongation and HIV-1 propagation mechanisms. It is not suited for broad CDK inhibition or protocols needing long-term stock solution storage. Proper solubility and handling are essential for reliable results.

• LY364947: Precision TGF-β Inhibition to Dissect EMT and Path

  2026-06-15

  Explore how LY364947, a potent TGF-β type I receptor kinase inhibitor, enables advanced interrogation of EMT and signaling pathway interplay in preclinical research. This article offers a deep dive into mechanistic insights, assay design, and translational implications beyond protocol basics.

• Cyclopamine: Translational Leverage for Hedgehog Pathway Inh

  2026-06-14

  Explore how Cyclopamine, a benchmark Hedgehog signaling inhibitor, empowers translational researchers with mechanistic clarity, workflow precision, and emerging cross-domain relevance. This thought-leadership article bridges cancer biology, developmental teratogenicity, and epigenetic frontiers, with actionable protocol guidance and strategic foresight.

• Docetaxel in Cancer Chemotherapy Research: Experimental Work

  2026-06-13

  Docetaxel, a potent microtubule stabilization agent, is pivotal in unraveling chemoresistance and apoptosis pathways in cancer models. This article provides actionable protocols, optimization insights, and a translation of the latest reference findings to help researchers harness Docetaxel’s full experimental value.

• Alternariol in Mycotoxin Research: Protocols and Applied Ins

  2026-06-12

  Alternariol (AOH) is a cornerstone for unraveling mycotoxin-driven mechanisms—from hepatic fibrosis modeling to cytochrome P450 enzyme assays. This guide translates recent omics-based breakthroughs and hands-on workflows into actionable, reproducible strategies for advanced toxin and apoptosis research.

• CX-5461 Induces DNA Damage and Mitotic Catastrophe in Cervic

  2026-06-12

  The referenced study demonstrates that CX-5461, a selective RNA polymerase I inhibitor, suppresses cervical cancer cell proliferation through DNA damage and mitotic catastrophe, while also sensitizing cells to cisplatin. These mechanistic insights highlight CX-5461’s potential as a targeted approach for overcoming chemoresistance in cervical cancer.

• Isoliensinine Regulates MAPK/NF-κB to Mitigate Neuroinflamma

  2026-06-11

  This study demonstrates that isoliensinine confers neuroprotection against LPS-induced neuroinflammation in microglia by modulating the MAPK/NF-κB signaling pathway. Through detailed biochemical assays, the authors reveal that isoliensinine reduces oxidative stress and mitochondrial dysfunction, highlighting its potential for further investigation in Alzheimer’s disease models.

• Patient-Derived 3D Spheroids Advance Prostate Cancer Modelin

  2026-06-11

  Patient-derived, three-dimensional spheroid cultures from radical prostatectomy tissue provide a robust, translational in vitro model for organ-confined prostate cancer. This platform allows detailed drug response testing and preserves key tumor characteristics, addressing longstanding gaps in clinically relevant prostate cancer research.

• Bestatin Dissects Jasmonate Signaling: Insights from Chemica

  2026-06-10

  The reference study demonstrates how bestatin, an aminopeptidase inhibitor, acts as a specific chemical genetics probe to dissect jasmonate (JA) signaling in Arabidopsis. By identifying distinct bestatin-resistant mutants with altered JA responses, the research uncovers new components in plant defense and developmental regulation, illustrating the power of small-molecule tools for pathway dissection.

• UTP Solution: Precision Nucleotide for Advanced RNA Workflow

  2026-06-10

  APExBIO’s UTP Solution (100 mM) delivers unmatched purity and reliability for RNA synthesis, amplification, and metabolic studies. This article dissects experimental workflows, cross-validates innovations from leading research, and provides actionable troubleshooting strategies for molecular biologists seeking reproducible results.

471 records 9/32 page Previous Next First page 上5页 678910 下5页 Last page